Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 12 May 2026

Tuesday, 12 May 2026

Ceisteanna (1215)

Pádraig O'Sullivan

Ceist:

1215. Deputy Pádraig O'Sullivan asked the Minister for Health if she will outline what steps her Department is taking to address the fact that brexpiprazole and lurasidone, two antipsychotic medicines now recommended as first-line treatment options for females with first-episode psychosis in the first international clinical guideline of its kind published in March 2026, are currently licensed in Ireland but not reimbursable under community drugs schemes; and if she will make a statement on the matter. [35183/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Question No. 1216 answered with Question No. 1069.
Roinn